Abstract
The oxidation of oxyhemoglobin to methemoglobin has been found to be facilitated by low molecular weight iron(III) thiosemicarbazone complexes. This deleterious reaction, which produces hemoglobin protein units unable to bind dioxygen and occurs during the administration of iron chelators such as the well-known 3-aminopyridine-2-pyridinecarbaldehyde thiosemicarbazone (3-AP; Triapine), has been observed in the reaction with FeIII complexes of some members of the 3-AP structurally-related thiosemicarbazone ligands derived from di-2-pyridyl ketone (HDpxxT series). We have studied the kinetics of this oxidation reaction in vitro using human hemoglobin and found that the reaction proceeds with two distinct time-resolved steps. These have been associated with sequential oxidation of the two different oxyheme cofactors in the α and β protein chains. Unexpected steric and hydrogen-bonding effects on the FeIII complexes appear to be the responsible for the observed differences in the reaction rate across the series of HDpxxT ligand complexes used in this study.
Graphical abstract
Similar content being viewed by others
Abbreviations
- 3-AP:
-
3-Amino-2-pyridinecarboxaldehyde thiosemicarbazone
- DeoxyHb:
-
Deoxyhemoglobin
- DFO:
-
Desferrioxamine B
- Hb:
-
Hemoglobin
- HbO2 :
-
Oxyhemoglobin
- HDpT:
-
Di-2-pyridyl ketone thiosemicarbazone
- HDp4eT:
-
Di-2-pyridyl ketone 4-ethylthiosemicarbazone
- HDp4mT:
-
Di-2-pyridylketone 4-methylthiosemicarbazone
- HDp44mT:
-
Di-2-pyridyl ketone 4,4-dimethylthiosemicarbazone
- MetHb:
-
Methemoglobin
References
Shikama K (1998) Chem Rev 98:1357–1374
Eaton WA, Henry ER, Hofrichter J, Mozzarelli A (1999) Nat Struct Biol 6:351–358
Wright RO, Lewander WJ, Woolf AD (1999) Ann Emerg Med 34:646–656
Yubisui T, Miyata T, Iwanaga S, Tamura M, Takeshita M (1986) J Biochem 99:407–422
Brooks J (1935) Proc R Soc Lond B Biol Sci 118:560–577
Tsuruga M, Shikama K (1997) Biochim Biophys Acta 1337:96–104
Mansouri A, Winterhalter KH (1973) Biochemistry 12:4946–4949
Valdes R, Vickers LP, Halvorson HR, Ackers GK (1978) Proc Natl Acad Sci USA 75:5493–5496
Griffon N, Baudbin V, Dieryck W, Dumoulin A, Pagnier J, Poyart C, Marden MC (1998) Protein Sci 7:673–680
Park S-Y, Yokoyama T, Shibayama N, Shiro Y, Tame JRH (2006) J Mol Biol 360:690–701
Eguchi LA, Saltman P (1984) J Biol Chem 259:14337–14338
Eguchi LA, Saltman P (1987) Inorg Chem 26:3665–3669
Bakar DA, Saltman P, Thériault Y, Wright PE (1991) Biochim Biophys Acta 1079:182–196
Harrington JP, Hicks RL (1994) Int J Biochem 26:1111–1117
Ilkowska E, Lewiński K, van Eldik R, Stochel G (1999) J Biol Inorg Chem 4:302–310
Ilkowska E, van Eldik R, Stochel G (1997) J Biol Inorg Chem 2:603–610
Kawanishi S, Caughey W (1985) J Biol Chem 260:4622–4631
Mauk AG, Gray HB (1979) Biochem Biophys Res Commun 86:206–210
Lappin AG (1994) Redox mechanisms in inorganic chemistry. Horwood, Chichester
Hegetschweiler K, Saltman P, Dalvit C, Wright PE (1987) Biochim Biophys Acta 912:384–397
Attia S, Kolesar J, Mahoney M, Pitot H, Laheru D, Heun J, Huang W, Eickhoff J, Erlichman C, Holen K (2008) Invest New Drugs 26:369–379
Gojo I, Tidwell ML, Greer J, Takebe N, Seiter K, Pochron MF, Johnson B, Sznol M, Karp JE (2007) Leuk Res 31:1165–1173
Knox JJ, Hotte SJ, Kollmannsberger C, Winquist E, Fisher B, Eisenhauer EA (2007) Invest New Drugs 25:471–477
Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M (2003) Clin Cancer Res 9:4092–4100
Wadler S, Makower D, Clairmont C, Lambert P, Fehn K, Sznol M (2004) J Clin Oncol 22:1553–1563
Kunos CA, Radivoyevitch T, Ingalls ST, Hoppel CL (2012) Future Oncol 8:145–150
Kunos CA, Waggoner S, von Gruenigen V, Eldermire E, Pink J, Dowlati A, Kinsella TJ (2010) Clin Cancer Res 16:1298–1306
Mackenzie M, Saltman D, Hirte H, Low J, Johnson C, Pond G, Moore M (2007) Invest New Drugs 25:553–558
Odenike OM, Larson RA, Gajria D, Dolan ME, Delaney SM, Karrison TG, Ratain MJ, Stock W (2008) Invest New Drugs 26:233–239
Traynor AM, Lee JW, Bayer GK, Tate JM, Thomas SP, Mazurczak M, Graham DL, Kolesar JM, Schiller JH (2010) Invest New Drugs 28:91–97
Yen Y, Margolin K, Doroshow J, Fishman M, Johnson B, Clairmont C, Sullivan D, Sznol M (2004) Cancer Chemother Pharmacol 54:331–342
Yu Y, Kalinowski DS, Kovacevic Z, Siafakas AR, Jansson PJ, Stefani C, Lovejoy DB, Sharpe PC, Bernhardt PV, Richardson DR (2009) J Med Chem 52:5271–5294
Richardson DR, Sharpe PC, Lovejoy DB, Senaratne D, Kalinowski DS, Islam M, Bernhardt PV (2006) J Med Chem 49:6510–6521
Whitnall M, Howard J, Ponka P, Richardson DR (2006) Proc Natl Acad Sci USA 103:14901–14906
Yuan J, Lovejoy DB, Richardson DR (2004) Blood 104:1450–1458
Bernhardt PV, Martinez M, Rodriguez C, Vazquez M (2012) Dalton Trans 41:2122–2130
Kalinowski DS, Yu Y, Sharpe PC, Islam M, Liao Y-T, Lovejoy DB, Kumar N, Bernhardt PV, Richardson DR (2007) J Med Chem 50:3716–3729
Chaston TB, Lovejoy DB, Watts RN, Richardson DR (2003) Clin Cancer Res 9:402–414
Quach P, Gutierrez E, Basha MT, Kalinowski DS, Sharpe PC, Lovejoy DB, Bernhardt PV, Jansson PJ, Richardson DR (2012) Mol Pharmacol 82:105–114
Zijlstra W, Buursma A, Meeuwsen-Van der Roest W (1991) Clin Chem 37:1633–1638
Maeder M, King P (2013) ReactLab Kinetics. Jplus Consulting, Perth
Bernhardt PV, Bozoglian F, Macpherson BP, Martinez M, Merbach AE, Gonzalez G, Sienra B (2004) Inorg Chem 43:7187–7195
Bell CA, Bernhardt PV, Gahan LR, Martinez M, Monteiro MJ, Rodriguez C, Sharrad CA (2010) Chem Eur J 16:3166–3175
Wittenberg JB, Wittenberg BA, Peisach J, Blumberg WE (1970) Proc Natl Acad Sci USA 67:1846–1853
Perrella M, Shrager RI, Ripamonti M, Manfredi G, Berger RL, Rossi-Bernardi L (1993) Biochemistry 32:5233–5238
Algarra AG, Fernández-Trujillo MJ, Basallote MG (2012) Chem Eur J 18:5036–5046
Basallote MG, Fernández-Trujillo MJ, Pino-Chamorro JÁ, Beltrán TF, Corao C, Llusar R, Sokolov M, Vicent C (2012) Inorg Chem 51:6794–6802
Espenson JH (1981) Chemical kinetics and reaction mechanisms. McGraw-Hill, New York
Wilkins RG (1991) Kinetics and mechanisms of reactions of transition metal complexes. VCH, Weinheim
Tobe ML, Burgess J (1999) Inorganic reaction mechanisms. Addison Wesley Longman, Harlow
Spasojevic I, Armstrong SK, Brickman TJ, Crumbliss AL (1999) Inorg Chem 38:449–454
Santucci R, Ascoli F, Antonini E (1984) Biochim Biophys Acta 789:20–25
Sugita Y, Bannai S, Yoneyama Y, Nakamura T (1972) J Biol Chem 247:6092–6095
Marcus RA (1993) Angew Chem Int Ed 32:1111–1121
Moser CC, Keske JM, Warncke K, Farid RS, Dutton PL (1992) Nature 355:796–802
Bernhardt PV, Martinez M, Rodriguez C (2010) Eur J Inorg Chem 2010:562–569
Bernhardt PV, Bozoglian F, Macpherson BP, Martinez M (2005) Coord Chem Rev 249:1902–1916
Martinez M, Pitarque M-A (1995) J Chem Soc Dalton Trans 4107–4111
Martinez M, Pitarque M-A, van Eldik R (1997) Inorg Chim Acta 256:51–59
Bernhardt PV, Sharpe PC, Islam M, Lovejoy DB, Kalinowski DS, Richardson DR (2009) J Med Chem 52:407–415
Acknowledgments
Financial support from the Australian Research Council (P.V.B.), the National Health and Medical Research Council of Australia (project grants and a Senior Principal Research Fellowship to D.R.R.), and the Spanish Ministerio de Ciencia e Innovación (CTQ2012-37821-C02-01, C.R., M.M., and P.V.B.) is gratefully acknowledged. M.T.B. is grateful for scholarship support from King Abdul Aziz University (Jeddah, Saudi Arabia).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Basha, M.T., Rodríguez, C., Richardson, D.R. et al. Kinetic studies on the oxidation of oxyhemoglobin by biologically active iron thiosemicarbazone complexes: relevance to iron-chelator-induced methemoglobinemia. J Biol Inorg Chem 19, 349–357 (2014). https://doi.org/10.1007/s00775-013-1070-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-013-1070-9